Skip to main content
Joel Gore, MD, Cardiology, Worcester, MA

Joel M Gore MD

Adult Congenital Heart Disease, Interventional Cardiology


Professor, Medicine, University Massachusetts Medical School

Join to View Full Profile
  • 55 Lake Ave NDepartment of Cardiovascular MedicineWorcester, MA 01655

  • Phone+1 774-441-6500

  • Fax+1 774-441-7657

Dr. Gore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Cardiovascular Disease, 1980 - 1982
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 1977 - 1980
  • University of Calgary Faculty of Medicine
    University of Calgary Faculty of MedicineClass of 1977

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1978 - 2027
  • CT State Medical License
    CT State Medical License 2004 - 2013
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Fellow (FACP) American College of Physicians, 2007
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical Investigations Twenty-Five Year Trends (1986-2011) in Hospital Incidence and Case-Fatality Rates of Ventricular Tachycardia and Ventricular Fibrillation Compl...  
    Catarina I Kiefe, Chad E Darling, Robert J Goldberg, Joel M Gore, ScienceDirect
  • Hyperglycemia and Risk of Ventricular Tachycardia Among Patients Hospitalized with Acute Myocardial Infarction  
    Catarina I Kiefe, Joel M Gore, Robert J Goldberg, Chad E Darling, BioMed Central

Press Mentions

  • Rivaroxaban Approved to Prevent CV Events in Patients with CAD or PAD
    Rivaroxaban Approved to Prevent CV Events in Patients with CAD or PADOctober 15th, 2018
  • Cardiogenic Shock Remains a Deadly Complication of Acute MI No Matter When It Develops
    Cardiogenic Shock Remains a Deadly Complication of Acute MI No Matter When It DevelopsJune 9th, 2017
  • Statin-Intolerant Patients Face Higher Risk for Recurrent MI
    Statin-Intolerant Patients Face Higher Risk for Recurrent MIMarch 14th, 2017
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: